mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for DTNA
Gene summary
Basic gene Info.Gene symbolDTNA
Gene namedystrobrevin, alpha
SynonymsD18S892E|DRP3|DTN|DTN-A|LVNC1
CytomapUCSC genome browser: 18q12
Type of geneprotein-coding
RefGenesNM_001128175.1,
NM_001198938.1,NM_001198939.1,NM_001198940.1,NM_001198941.1,
NM_001198942.1,NM_001198943.1,NM_001198944.1,NM_001198945.1,
NM_001390.4,NM_001391.5,NM_001392.4,NM_032975.3,
NM_032978.6,NM_032979.4,NM_032980.3,NM_032981.4,
Descriptiondystrobrevin alphadystrophin-related protein 3
Modification date20141207
dbXrefs MIM : 601239
HGNC : HGNC
Ensembl : ENSG00000134769
HPRD : 03141
Vega : OTTHUMG00000132309
ProteinUniProt: Q9Y4J8
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_DTNA
BioGPS: 1837
PathwayNCI Pathway Interaction Database: DTNA
KEGG: DTNA
REACTOME: DTNA
Pathway Commons: DTNA
ContextiHOP: DTNA
ligand binding site mutation search in PubMed: DTNA
UCL Cancer Institute: DTNA
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for DTNA
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
C246C246SCOAD1
C270W272CLUAD1
C246C246SLUSC1
C258R257LOV1
H284M286ISTAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for DTNA
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
C246C246S-1.3307404
H284M286I-1.1969534
C270W272C-0.81175987
C258R257L-0.442017
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for DTNA from PDB

Top
Differential gene expression and gene-gene network for DTNA
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of DTNA and the right PPI network was created from samples without mutations in the LBS of DTNA. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for DTNA
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C1858725Noncompaction of Left Ventricular Myocardium, Familial Isolated, Autosomal Dominant 11Biomarker, GeneticVariation

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for DTNA
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of DTNA go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of DTNA
Multiple alignments for Q9Y4J8 in multiple species
LBSAA sequence# speciesSpecies


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas